Michael Snee of St. James’s Institute of Oncology, Leeds, United Kingdom gives an informative talk on stereotactic ablative radiotherapy (SABR), an alternative treatment for peripheral early stage lung cancer in higher risks patients who are unable to undergo surgery. Dr. Snee provides an overview of SABR, including patient selection and current comparative trials.
This presentation was originally given during the SCTS Ionescu University program at the 2015 Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland. This content is published with the permission of SCTS. Please click here for more information on SCTS educational programs.
